Medical device manufacturers must choose a sterilization process for their devices before they go to market. There are several types of sterilization process, but one of the two most common forms is radiation. (The other is ethylene oxide.)
With the international ANSI/AAMI/ISO 11137-1 and 11137-2 standards governing development, validation, and routine control of radiation sterilization, manufacturers can readily implement the appropriate practices for radiation sterilization into their manufacturing process.
Once the sterilization dose is established, the manufacturer has to demonstrate that this dose can be delivered consistently to the product and monitor the sterilization process routinely to confirm that this has been achieved.
Occasionally products will fail an initial sterilization dose establishment or a sterilization dose audit. When that happens, it can slow or stop production. The first thing to remember is all failures are different. There is no benefit in jumping to conclusions or making quick assumptions and guesses.
Manufacturers can identify and correct failures when they approach them properly, and can always consult with a testing laboratory if they have questions regarding a failure. Here is a list of the most common causes of failures and a brief description of how to combat them. 
Establishing the Dose
There are three methods a testing laboratory uses to establish a radiation sterilization dose: Verification Dose Maximum (VD max ), Method 1 and Method 2.
• Manufacturers select the VD max radiation approach most frequently. Not coincidentally, it is also the most cost effective. This approach determines for manufacturers if they can sterilize their medical device with the most typical radiation dose-25kGy. The method requires a bioburden determination on 30 product items, 10 each from three different batches. There is a maximum bioburden limit that applies in order to use this method. The laboratory uses the results of the bioburden test in a table from ANSI/ AAMI/ISO 11137-2 to determine the appropriate verification dose. They apply this verification dose to 10 additional product items from one batch followed by a test of sterility on the irradiated product items. If one or fewer product items tests positive for microorganism growth, the sterilization dose is substantiated. The laboratory must perform additional testing if there are two positives. If three or more of the product items test positive for growth, the sterilization dose is not substantiated. In the case of a failure in substantiation, manufacturers must implement corrective action (e.g., make changes to the device manufacturing process to reduce the bioburden) and try again or use another method to establish the sterilization dose. VD max also has tables for substantiation of other, less often used, sterilization doses (i.e. 15.0, 17.5, 20.0, 22.5, 27.5, 30.0, 32.5, and 35 kGy) in AAMI TIR33.
• Method 1 is a great choice for establishing the sterilization dose if manufacturers find they need to use a lower dose of radiation because of the radiation compatibility of materials comprising their device or if a sterility assurance level (SAL) other than 10 -6 is necessary (e.g., 10
-3 or 10 -4
). Different materiAfter completing a bioburden extraction, a nelson labs study director filters the solution to grow the microorganisms and obtain a bioburden count.
als react differently to radiation and subjecting them to higher doses can be harmful. They may need a lower dose that corresponds more closely with their product's bioburden. Method 1 for dose establishment follows a similar testing scheme as VD max , but the laboratory completes the test of sterility on 100 product items after exposure to the verification dose instead of 10. To do this, the laboratory determines the verification dose using a different table from ANSI/AAMI/ISO 11137-2. Out of the 100 product items tested for sterility, the verification is accepted if two or fewer product items test positive for growth and the sterilization dose can be read from the table in ANSI/AAMI/ISO 11137-2. If three or more product items test positive, manufacturers need to implement corrective action (e.g., make changes to their manufacturing process to reduce the bioburden) and try again or use another approach to establish the sterilization dose. Because of the larger sample size, Method-1 validation is more costly than VD max .
• Method 2, the most infrequently selected method of establishing the sterilization dose, determines the lowest dose of radiation possible to sterilize the device. It does not use an established dosing table. Instead it determines the radiation resistance of the bioburden by using multiple radiation doses (incremental dosing) on a number of product items (groups of 60 product items receiving eight or nine different doses) to determine at which dose negative tests of sterility are obtained from the irradiated product items. These data are used to calculate a verification dose which is applied to an additional 100 product items. The appropriate sterilization dose is then determined by calculation using defined equations.
Once the dose establishment process is complete, manufacturers don't need to repeat the process of establishing the sterilization dose unless they make a change to the device or manufacturing process. However, a periodic sterilization dose audit is required (usually quarterly) for all methods of establishing the sterilization dose. Sterilization dose audits ensure the established radiation dosage remains appropriate. Changes in assembly processes, device composition, and assembly environment can affect the bioburden and potentially necessitate a change in sterilization dose.
Choosing the Appropriate Method
A credible laboratory will offer the manufacturer guidance and advice on what method of establishing the sterilization dose that will work best. When manufacturers know the three dose establishment methods and the most common causes of failures and their differences, they are more prepared to make educated decisions that will benefit their organizations and speed their device approvals in the following ways: • Development decisions. If manufacturers understand the radiation dose likely needed for their device sterilization at the beginning of development, it allows them to pick composition materials that can handle radiation without damage or degradation. They can plan for the lowest cost method.
• Radiation dose. Different devices can handle different amounts of radiation. When manufacturers understand the range of radiation levels their device can handle, it makes it easier for sterilization outsourcers to guarantee they can hit the range. • Planning. If device makers know the general radiation sterilization requirements up front, it allows them to plan for product items, sterilization costs and processes well in advance of the product's release. 
